Loading...

Cancer Supportive Care Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2027

A07133
Pages: NA
Sep 2020 | 66 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cancer Supportive Care Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2027

Request Now !

Cancer supportive drugs are used for the treatment of various infections caused due to chemotherapy, and other infections. These drugs are used to reduce the harmful reactions of cancer treatment by protecting organs of the body. These supportive drugs are usually given with the cancer drugs to avoid infections and are also called as protective drugs. In few cases, the cancer treatments are stopped or doses are lowered due to various reasons such as low count of blood cells. These cancer supportive drugs such as colony-stimulating factors (CSFs) help patients to continue with cancer treatment. Various cancer treatments provide various side effects such as pain, depression, fertility problems, fatigue, sexual problems, bone diseases and other side effects. With these side effects, the physicians prefer to use supportive care drugs with ongoing cancer treatments. These factors are expected to drive the cancer supportive care drugs market. 

 

Cancer-Supportive-Care-Drugs

Market scope and structure analysis:

              Report Metric

                                      Details

  Market size available for years

   2020–2027

  Base year considered

  2019

  Forecast period

  2021–2027

  Forecast units

  Value ($USD)

  Segments covered

  Drug class and Distribution channel

  Geographies covered

North America (U.S. and Canada), Europe (Germany, UK, Spain, Italy, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and the Rest of Asia-Pacific), LAMEA  (Brazil, Saudi Arabia, South Africa  and the Rest of LATAM)

  Companies covered

Novartis Ag., Johnson & Johnson, Tesaro, Amgen Inc., Baxter International Inc., APR Applied Pharma Science Research S.A., Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Kyowa Hakko Kirin Co Ltd., and Acacia Pharma Ltd.

 

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

In 2018, 18.1 million new cancer cases were detected and diagnosed globally. Moreover, the cases are increasing in the coming years.  . Cancer therapies can cause many side effects as it involves high range radiations. Cancer supportive care drugs are used to reduce the side effects of therapies. This is the reason that cancer supportive care drugs are getting more popularity and it is directly related to the growth of the cancer supportive care drug market. The main side effects caused by cancer treatment are neutropenia, nausea, vomiting anemia, and pain. The rise in the number of people suffering from these effects due to cancer therapies is driving the growth.

Further, increasing advancements in drugs that have lesser side effects are discovered and preferred by the patients and doctors. This is directly affecting the growth and share of the cancer supportive care drugs market. Further, side effects due to these cancer supportive drugs and stringent regulatory processes are the restraining factors to the growth of market, which fluctuate the cancer supportive care drugs market share.

Currently many products are made and are on clinical trials so that they can be used for treating reactions of cancer therapy. Some of the drugs are seen to result in new molecular targets for handling the side effects in the cancer supportive care drug market. Market vendors are working toward knowing the new targets and developing stronger drug pipelines. They are also working to provide better solutions for the people suffering from various side effects of cancer treatment. The governments and non-government organizations are taking initiatives for spreading awareness, which is expected to fuel the growth of the cancer supportive care drugs market.

COVID-19 Scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Cancer patients with leukemia, lymphoma, or myeloma receiving cancer treatments and those with recent bone marrow or stem cell transplants could be affected by COVID-19. The cancer patients are at higher risk for COVID-19.

Key segments covered:

             Segments

                              Sub-segments

  Drug class

  • ESAs(Erythropoiesis stimulating agent)
  • G-CSFs (Granulocyte colony-stimulating factors)
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs (Non-Steroidal auto inflammatory  drugs)
  • Topicals
  • Others

Distribution channel

 

 

  • Hospitals
  • Clinics
  • Retails

 

Key benefits of the report:

  • This study presents the analytical depiction of the global cancer supportive care drug industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global cancer supportive care drug market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed cancer supportive care drugs market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the cancer supportive care drug market research report:

  • Who are the leading market players active in the cancer supportive care drug market?
  • What are the current trends that will influence the cancer supportive care drugs market in the next few years?
  • What are the driving factors, restraints, and opportunities in the cancer supportive care drugs market?
  • What can be the challenges for the global cancer supportive care drug market in future?
  • What are the projections for the future that will help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Cancer Supportive Care Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts